We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Automating Cell-Based Assays to Determine Viral Vector Titer – Oxford Biomedica & Hamilton Robotics

Video  
Published: January 23, 2023
 

In this video, Oxford Biomedica, an innovative global gene and cell therapy company with operations in the UK and US, describes the automation of an assay requiring a 10-day cell-based workflow, using an integrated Hamilton Microlab STAR liquid handler and CECULA's Graphical User Interface (GUI).


Download the Case Study here: https://hubs.li/Q01xk4kF0

Brought to you by
Interested in seeing more content from Hamilton?
Discover all their latest news, webinars, products and more by clicking the link below.
Related Topic Pages
Lab of the Future
Gene and Cell Therapy
Automation
Advertisement
Chosen for You
A picture of differentiated SH-SY5Y on Revivocell NANOSTACKS™.
Industry Insight

Redefining Preclinical Testing With High-Complexity In Vitro Models
A lab worker pipetting media into a cell culture dish.
Industry Insight

Recreating Organ-Specific Tumor Environments In Vitro
Cell Microsystems and Colossal Webinar
Webinar

Reviving the Past, Safeguarding the Future: Challenges and Innovations in Cell Culture for De-Extinction
Advertisement
Advertisement
Decoratvive background images
Never miss a story
with the Breaking Science News daily newsletter